Pervin Ejder

Biography

  Ejder Kimya has seen these changes in  the Turkish business environment reified in the demands of our customers: there is a desire for cheaper APIs and excipients and a demand for cheaper raw materials. Our customers have come to understand that there are trade-offs associated with using these products that are visible in product quality. While we have not seen the Turkish pharmaceutical manufacturer reduce their quality standards, there is a deep desire on the part of manufacturers to optimize their supply chain dynamics. Price has become the primary concern. Their concern, first and foremost, is their ability to bring their products to market and product documentation.

Research Interest

  Ejder Kimya sees strong growth in its  pharmaceutical, laboratory and cosmetics businesses. We can, as an organization, transform into a multinational company involved in the provision of these services. As the Turkish pharmaceutical industry grows outside of its historical borders, we will grow in tandem. We foresee opening an office outside of Turkey, either in the Middle East or North Africa. This said, the Turkish industry is volatile. Fifteen years ago we might have been able to plan for a five-year period, today, but business environments shift over the course of a period as short as quarters. Much could change in the near future, but we have medium- and long-term targets to achieve. We will progress on our own path.